Abstract
A facile and broadly applicable method for the regiospecific N-arylation of benzotriazoles is reported. Copper-mediated reactions of diverse 1-hydroxy-1H-benzotriazoles with aryl boronic acids lead to 1-aryl-1H-benzotriazole 3-oxides. A N1-OH → N3 prototropy in the 1-hydroxy-1H-benzotriazoles is plausibly the underlying basis, where the tautomer is captured by the boronic acid, leading to C–N (not C–O) bond formation. Because the N–O bond in amine N-oxides and 1-hydroxy-1H-benzotriazoles can be easily reduced by diboron reagents such as (pinB)2 and B2(OH)4, exposure of the 1-aryl-1H-benzotriazole 3-oxides to B2(OH)4 then leads to facile reduction of the N–O bond resulting in diverse, regiospecifically-arylated benzotriazoles. Thus, the N-hydroxyl group in 1-hydroxy-1H-benzotriazoles acts as a disposable arylation director.
Keywords: arylation, benzotriazoles, directing group, copper, boronic acid
Graphical abstract

Introduction
Among heterocycles, benzotriazoles are an important family of compounds with wide-ranging uses. In medicinal chemistry, many have shown important biological activities.[1–4] In relation to the present work, 1-aryl-1H-benzotriazoles display promise against various diseases. Some examples containing N-aryl-linked benzotriazoles are shown in Figure 1. Among these, the tetrahydronaphthalene derivative is a ligand for retinoid X receptors, and showed significant activity against type-2 diabetes in vivo.[5] The pyrimidine-benzotriazole conjugates were shown to be potent inhibitors of JNK1 (mitogen-activated protein kinase 1), with selectivity over JNK2.[6] The acridine derivatives showed antibacterial activity, comparable to ampicillin, against S. areus, B. subtilis, and E. coli.[7] The benzotriazolyl chalcones demonstrated antifilarial activity against Setaria cervi causing parasitic death,[8] and against Plasmodium falciparum.[9]
Figure 1.

N1-aryl benzotriazoles possessing biological activities.
Also, benzotriazoles are corrosion inhibitors for copper and copper alloys,[10] they are found in formulations that contact metals (such as aircraft deicing and brake fluids, and in metal-cutting fluids),[11] and are antifog agents in photographic applications.[12] Benzotriazoles are important in organic synthesis,[13] including as ligands in cross-coupling reactions.[14]
Many methods, metal-catalyzed and uncatalyzed, have been developed for the N-arylation of benzotriazoles, but reaction at the N1 and N2 and formation of regioisomeric products from unsymmetrical benzotriazoles have to be contended with. Among methods not involving metal-mediated processes, the most common is diazotization of N-aryl-o-phenylenediamines.[15] Also, reaction of 2-(arylamino)iminophosphoranes with NaNO2/AcOH results in N1-arylbenzotriazoles.[16] Perhaps the most convenient access is via cycloaddition of arynes with aryl azides but this can yield regioisomers with unsymmetrical arynes.[17] Among methods involving metals, Pd-mediated C–H bond activation/C–N bond formation in 1,3-diphenyltriaz-1-enes[18] and 1,7-Pd migration-cyclization-demethylation of 3-methyl-1,3-diphenyltriaz-1-enes have been reported.[19] 1H-Benzotriazole itself has been used as a substrate for Cu-mediated arylation. Examples are: the Cu(OAc)2-catalyzed reaction of an aryllead derivative at 140 °C (1 example, N1/N2 ratio = 3.8 : 1),[20] arylation with a CuI-diamine system at 110 °C (2 examples, N1/N2 ratio > 25 : 1),[21] and CuBr2/n-Bu4N+F− mediated arylation at 145 °C (in 2 examples, N1/N2 ratios = 1.3–2.7 : 1).[22] Cyclization of o-halo-1,3-diphenyltriaz-1-enes to N1-aryl benzotriazoles has been accomplished via catalysis by CuI.[23–25] In a Cu(OAc)2-catalyzed method, 1H-benzotriazole underwent reaction with substituted thiophenes, furans, and pyrroles, in the presence of Selectfluor.[26] N-(2-Hydroxyaryl)benzotriazoles have been prepared by O-arylation with diaryliodonium triflates, followed by a [33] sigmatropic rearrangement.[27] A summary of these methods is shown in Scheme 1.
Scheme 1.

Previous approaches to N1-aryl benzotriazoles.
Results and Discussion
In this report, we present a new approach to regiospecific N1 arylation of benzotriazoles that is directed by a remote hydroxyl group. In previous work, we demonstrated facile reduction of 1-hydroxy-1H-benzotriazoles (BtOH) by exposure to B2(OH)4 and Et3N in MeCN (Scheme 2).[28] In that work we proposed that a possible mechanism for the reduction could involve the N1-OH → N3 prototropy, which would expose an N-oxide type of intermediate. Such a species could be reduced by a diboron reagent. In this context, we and others have shown general approaches for the reduction of N–O bonds in amine N-oxides and O6-(benzotriazolyl) purine nucleosides by diboron reagents.[29–31] Tautomerism in BtOH is known to be solvent dependent. The N-hydroxy form has been crystallized from water-free EtOH/Et2O after drying the compound over P2O5 at 50 °C, whereas the N-oxide form was obtained from MeOH/H2O.[32] Also, acylation of BtOH can produce O- or N-acylation, depending upon the polarity of the reaction medium,[33–35] and the O-acyl compound completely isomerizes to the N-acyl form in the solid state.[35]
Scheme 2.

Reduction of BtOH derivatives and a proposed approach to hydroxyl-directed N-arylation of benzotriazoles.
On the basis of the tautomerism exhibited by 1-hydroxy-1H-benzotriazoles[32–35] and our prior results,[28] we reasoned that it should be possible to capture the N-oxide tautomer in a Chan-Lam-Evans type of reaction.[36–38] The ensuing product would be an N1-aryl-1H-benzotriazole 3-oxide, which could then be reduced to the corresponding 1H-benzotriazole, removing the directing hydroxyl handle. We should note that reaction of BtOH and p-Me-PhB(OH)2, using Cu(OAc)2 and either pyridine or Et3N, has previously been reported.[39] The product obtained was identified as the O-arylated compound, but our results herein indicate a different outcome. While our work was being completed a similar method for Cu-catalyzed N-vinylation of 1-hydroxy-1H-benzotriazoles, leading the N-oxides was reported.[40] In that work, several reactions of BtOH with aryl boronic acids were also recorded, but only two substituted 1-hydroxy-1H-benzotriazoles were studied.[40] Comparisons of the methods are presented later.
Our present work commenced with evaluation of conditions for the reaction of 1-hydroxy-1H-benzotriazole (BtOH) with PhB(OH)2, at room temperature (data in Table 1). Between ClCH2CH2Cl and CH2Cl2, the latter proved to be superior, and no reaction occurred in DMSO (entries 1–3). We reasoned that one possible cause for the promising but modest result in CH2Cl2 could be the water solubility of what we considered was 1-phenyl-1H-benzotriazole 3-oxide. This notion was supported by the improved 77% yield that was obtained when the reaction mixture was directly chromatographed, without aqueous workup (entry 4). Replacement of pyridine with either Et3N or 2,2′-bipyridine gave inferior results. Lowering the amount of Cu(OAc)2 (entries 7 and 8) also proved to be detrimental, clearly indicating the need for a stoichiometric amount (98% Cu(OAc)2 costs < $1/mol).
Table 1.
Optimization of conditions for reaction of BtOH with PhB(OH)2.[a]
| |||
|---|---|---|---|
| Entry | Solvent | Conditions | Yield [%][b] |
| 1 | ClCH2CH2Cl | Cu(OAc)2 (1 equiv.), pyridine (4 equiv.) | 27[c] |
| 2 | CH2Cl2 | Cu(OAc)2 (1 equiv.), pyridine (4 equiv.) | 42[c] |
| 3 | DMSO | Cu(OAc)2 (1 equiv.), pyridine (4 equiv.) | NR[d] |
| 4 | CH2Cl2 | Cu(OAc)2 (1 equiv.), pyridine (4 equiv.) | 77[e] |
| 5 | CH2Cl2 | Cu(OAc)2 (1 equiv.), Et3N (4 equiv.) | 30[e] |
| 6 | CH2Cl2 | Cu(OAc)2 (1 equiv.), 2,2′-bipyridine (2 equiv.) | 10[e] |
| 7 | CH2Cl2 | Cu(OAc)2 (0.25 equiv.), pyridine (4 equiv.) | 14[e] |
| 8 | CH2Cl2 | Cu(OAc)2 (0.5 equiv.), pyridine (4 equiv.) | 26[e] |
| 9 | CH2Cl2 | CuI (1 equiv.), pyridine (4 equiv.) | 11[e] |
| 10 | CH2Cl2 | CuCl (1 equiv.), pyridine (4 equiv.) | 14[e] |
Reactions were conducted with 100 mg of BtOH in 2 mL of solvent, under a balloon filled with O2 gas.
Yield is of isolated and chromatographically purified product.
Reaction mixture was subjected to an aqueous workup.
NR = no reaction.
Reaction mixture was directly chromatographed without aqueous workup.
Whereas evidence pointed to the product of this Cu-mediated transformation to be 1-phenyl-1H-benzotriazole 3-oxide, confirmation was necessary. Therefore, the product was crystallized and analyzed crystallographically (Figure 2).[41] This unequivocally indicated that the product was the expected N-oxide and not the O-aryl product.
Figure 2.

X-ray crystallographic structure of 1-phenyl-1H-benzotriazole 3-oxide (1) and crystal packing (thermal ellipsoids are shown at the 50% probability level).
Having established both reaction conditions and the structure of the product from the arylation step, we proceeded to evaluate the generality of the reaction. Several aryl boronic acids were reacted with BtOH and these data are summarized in Figure 3. Some comparisons to the previous report[40] are perhaps instructive. Our reactions were typically conducted with 1.1 equiv. of the aryl boronic acid (except where indicated within parenthesis in Figure 3) and 4 equiv. of pyridine, in CH2Cl2 at room temperature, in the presence of molecular sieves. The reported reactions were conducted with 3 equiv. of the aryl boronic acid and 10 equiv. of pyridine, in 1,4-dioxane at 40 °C, in the presence of Na2SO4.[40] The product yields with phenyl and 2-naphthylboronic acid under both sets of conditions, were comparable (1: 77% in both cases, 10: 73% here versus 68% reported[40]). Thus, excess aryl boronic acid may not always be necessary, however, we observed yields to improve with excess aryl boronic acid in some cases where yields were low (9, 13, and 15). Notably, in both reports, a stoichiometric amount of Cu(OAc)2 was necessary.
Figure 3.

Products and yields from the reactions of BtOH with 1.1 equiv. of aryl boronic acids (yields in parentheses are from reactions with 2 equiv. of the boronic acid).
1-Hydroxy-1H-benzotriazoles are relatively straightforward to access[28,42] and so reactions of substituted benzotriazoles with various aryl boronic acids were investigated. Generally good yields were observed with 6-chloro BtOH and a superior yield was obtained in a reaction with 2 equiv. of PhB(OH)2. 6-Bromo BtOH reacted very well with just 1.1 equiv. of the three boronic acids. With 6-phenyl BtOH high yields were attained with all three boronic acids and, notably, excellent yields were obtained with p-nitrophenylboronic acid and 3-thienylboronic acid. The latter gave a modest yield with BtOH.
At this stage we decided to reduce all (26) 1-aryl-1H-benzotriazole 3-oxides. 1-Hydroxy-1H-benzotriazoles were reduced by B2(OH)4 and Et3N, under generally mild conditions.[28] In the present cases, because the products of the arylation reactions are already N-oxides, they were reduced with only B2(OH)4. The reduction products are shown in Scheme 3 and as can be seen from the reduction of 12 to 38, this reaction is also scalable.
Scheme 3.

Reduction of the 1-aryl-1H-benzotriazole 3-oxides with B2(OH)4.
Although the X-ray structure of compound 1 had hinted at the regiochemical outcome of these reactions, as a second step the 1H NMR data for 5-chloro-1-(p-tolyl)-1H-benzotriazole (44) were compared to those reported for 6-chloro-1-(p-tolyl)-1H-benzotriazole, and these are distinctly different.[43] As definitive proof of the regiospecificity of this chemistry, compound 44 was crystallized and a crystal structure was obtained (Figure 5).[44] This conclusively demonstrated the location of the aryl group relative to the halogen atom, substantiating our initial hypothesis that the N-hydroxyl group directs the arylation step, and that it can be used as a removable handle for the regiospecific N-arylation of benzotriazoles.
Figure 5.

X-ray crystal structure of 5-chloro-1-(p-tolyl)-1H-benzotriazole (44) and crystal packing (thermal ellipsoids are shown at the 50% probability level).
We also investigated reactions of 5,6-dichloro BtOH.[30] In this case, while performing the arylation and reduction as separate reactions, we observed that 5,6-dichloro-1-aryl-1H-benzotriazole 3-oxides were difficult to purify and were possibly prone to degradation. Thus, we decided to evaluate the arylation and reduction as a two-step, one-pot process (Table 2, entries 1–3). In three cases, after the N-arylation step (with 1.1 equiv. of each aryl boronic acid), the solvent was evaporated and the reduction was performed with B2(OH)4 in MeCN. In the phenyl case (53), a significant improvement in yield was observed, while modest yield improvements were observed in the 2-naphthyl (54) and p-bromophenyl (55) cases. The three final products were obtained without any difficulty. On the basis of the above observations three other two-step, one-pot reactions were conducted with 1.1 equiv. of the aryl boronic acids to assess if there was any advantage to be gained with the latter. Compounds 34, 39 and 43 were selected (Table 2, entries 4–6) due to the somewhat lower yields observed in the arylation step in these cases. The results indicate that no major yield advantage was gained via the two-step, one-pot approach, and that this may be beneficial when the intermediate N-oxide is prone to degradation.
Table 2.
Synthesis of six N-aryl-1H-benzotriazoles via two-step and two-step, one-pot processes.
| |||||
|---|---|---|---|---|---|
| Entry | X and Y | Ar = | Product | Two step | Two step, one pot |
| 1 | X = Y = Cl |
|
53 | 45% | 62% |
| 2 | X = Y = Cl |
|
54 | 34% | 39% |
| 3 | X = Y = Cl |
|
55 | 20% | 26% |
| 4 | X = Y = H |
|
34 | 54% | 50% |
| 5 | X = Y = H |
|
39 | 33% | 34% |
| 6 | X = H, Y = Cl |
|
43 | 48% | 42% |
As seen in Figure 1, azaheterocycles at the N1 position of a benzotriazole result in compounds with biological activity. Therefore, we decided to introduce a pyrimidine motif via the use of 2-methoxypyrimidine-4-boronic acid (Scheme 4). Cautioned by the lower yields observed in the reactions of heteroaryl boronic acids, two reactions were conducted: (a) one with 1.1 equiv. of the pyrimidine boronic acid, at room temperature over 24 h, and (b) the second with 2 equiv. of the boronic acid, also at room temperature, but over 48 h, due to the limited solubility of the boronic acid. As in reactions of BtOH with heteroaryl boronic acids (Figure 3), yields were modest (22% and 31%) with the higher equivalence giving the better yield. Nevertheless, this demonstrates that physiologically important motifs can be introduced via this methodology.
Scheme 4.

Synthesis of an N-aryl benzotriazole containing a biologically relevant pyrimidine motif.
Because these reactions were conducted in a non-polar solvent, we anticipated the N1-OH → N3 prototropy to be minor and thus, the hydroxyl form to be the major component under the reaction conditions. It is known that substituents on the benzotriazole can influence the extent of this tautomerism but, generally, the N-hydroxy form remains major in EtOH, whereas the N-oxide predominates in water.[45] However, we were curious to assess the energy differences between the N-hydroxy and N-oxide tautomers in a set of representative examples, in vacuo, in CH2Cl2 (the reaction solvent), and in water. For this we chose BtOH, 6-Cl-BtOH, 5,6-di-Cl-BtOH, 6-Ph-BtOH, and the corresponding N-oxides. DFT computations were conducted using the B3LYP/6-311++(d,p) basis set and the results are shown in Table 3 (see the Supporting Information for details).
Table 3.
Free energy differences between the N-oxide and N-hydroxy forms (GN-oxide − GN-hydroxy) in kcal/mol of 1-hydroxy-1H-benzotriazole and its derivatives.
| X, Y | ΔGvacuo | ΔGCH2Cl2 | ΔGH2O |
|---|---|---|---|
| H, H | –0.10 | –3.46 | –4.32 |
| H, Cl | 1.11 | –2.64 | –3.57 |
| Cl, Cl | 0.822 | –2.63 | –3.51 |
| H, Ph | 0.23 | 0.70 | 0.21 |
These data indicate that even in CH2Cl2, a solvent of modest dielectric constant (ε = 9.08), the N-oxide form is preferred for BtOH as well as its 6-Cl and 5,6-di-Cl derivatives, and this preference increases in water (ε = 78.54). However, these computations indicate a slight preference for the N-oxide form of BtOH in vacuo, but in the remaining three cases the N-hydroxy form is preferred. 6-Ph-BtOH is the exception, where under all conditions a preference for the N-hydroxy form is seen. Thus, the notion that substituents influence the tautomerism is supported by these computations but they also seem to indicate that the tautomerism could be altered in either direction.
On the basis of the mechanism proposed for the etherification of p-cresol with MeOH,[46] we anticipate a pathway as shown in Scheme 5. This proceeds by formation of an aryl-CuII species followed by oxidation to an aryl-CuIII by another CuII, reaction of the aryl-CuIII species with BtOH, reductive-elimination from the CuIII intermediate, and a reoxidation of the formed CuI to CuII.
Scheme 5.

A proposed catalytic cycle for the N-arylation of 1-hydroxy-1H-benzotriazoles.
In previous work,[40] species leading up to reductive elimination were evaluated by DFT computations. An N-coordinated intermediate that would produce the N-oxide product was slightly higher in energy (by 0.2 kcal/mol) than the corresponding O-coordinated species that would lead to O-arylation. However, the transition state leading to N-arylation was lower in energy (by 3 kcal/mol) as compared to that leading to O-arylation. Also, the N-oxide product is lower in energy (by 5.9 kcal/mol) than the O-aryl isomer. We now offer a computational perspective into the N-hydroxy/N-oxide tautomerism of BtOH, which is also a part of this overall process.
Conclusions
Herein, we have demonstrated a facile approach to the regiospecific N-arylation of 1H-benzotriazoles, which involves a Cu-mediated reaction with aryl boronic acids. We believe that the N1-OH → N3 prototropy in 1-hydroxy-1H-benzotriazoles, even in non-polar solvents, can be utilized to capture the N-oxide tautomer with aryl boronic acids. This arylation can then drive the reaction forward. This hypothesis is consistent with the formation of 1-aryl-1H-benzotriazole 3-oxides as intermediates. Facile reduction of these N-oxides with B2(OH)4 then yields the N1-aryl benzotriazoles. Thus, the hydroxyl moiety functions as an easily disposable arylation-directing group, rendering this a regiospecific N-arylation. Both our results and those previously published[40] indicate that the reaction requires stoichiometric Cu(OAc)2, but our reactions can be conducted at room temperature with nearly stoichiometric amounts of aryl boronic acids in most cases. In some cases where yields were lower, these could be improved by increasing the boronic acid stoichiometry to 2 equiv. The present data and those published[40] indicate that contrary to the anticipated formation of O-aryl ethers,[39] as from reactions of phenols with aryl boronic acids,[36,37] N-arylation is the operative mechanism in the reactions of 1-hydroxy-1H-benzotriazoles. As shown here, this can be exploited for the regiospecific N-arylation of benzotriazoles.
Supplementary Material
Figure 4.

Products and yields from the reactions of 6-substituted BtOH derivatives with 1.1 equiv. of aryl boronic acids (yield in parentheses is from reaction with 2 equiv. of the boronic acid).
Acknowledgments
Support of this work by NSF Grant CHE-1265687 to MKL as well as PSC CUNY awards to MKL and PP is gratefully acknowledged. We thank AllyChem for a sample of B2(OH)4 used in this work. Infrastructural support at CCNY was provided by NIH grant G12MD007603 from the National Institute on Minority Health and Health Disparities. We thank Dr. Gopal Subramaniam at Queens College for assistance in obtaining some NMR spectra. Computational results were obtained via the City University of New York High Performance Computing Center at the College of Staten Island that was supported, in part, by NSF awards CNS-0958379, CNS-0855217, ACI-1126113.
Footnotes
Supporting information for this article is available on the WWW under…
References
- 1.a) Ren Y, Zhang L, Zhou CH, Geng RX. Med Chem. 2014;4:640–662. [Google Scholar]; b) Peng XM, Cai GX, Zhou CH. Curr Topics Med Chem. 2013;13:1963–2010. doi: 10.2174/15680266113139990125. [DOI] [PubMed] [Google Scholar]; c) Suma BV, Natesh NN, Madhavan V. J Chem Pharm Res. 2011;3:375–381. [Google Scholar]
- 2.Top Curr Chem. Vol. 43 Springer International Publishing; Switzerland: 2014. The Chemistry of Benzotriazole Derivatives. [Google Scholar]
- 3.a) Verschueren KHG, Pumpor K, Anemülller S, Chen S, Mesters JR, Hilgenfeld R. Chem Biol. 2008;15:597–606. doi: 10.1016/j.chembiol.2008.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Wu CY, King KY, Kuo CJ, Fang JM, Wu YT, Ho MY, Liao CL, Shie JJ, Liang PH, Wong CH. Chem Biol. 2006;13:261–268. doi: 10.1016/j.chembiol.2005.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Bretner M, Baier A, Kopańska K, Najda A, Schoof A, Reinholz M, Lipniacki A, Piasek A, Kulikowski T, Borowski P. Antiviral Chem Chemother. 2005;16:315–326. doi: 10.1177/095632020501600504. [DOI] [PubMed] [Google Scholar]; d) Kopańska K, Najda A, Żebrowska J, Chomicz L, Piekarczyk J, Myjak P, Bretner M. Bioorg Med Chem. 2004;12:2617–2624. doi: 10.1016/j.bmc.2004.03.022. [DOI] [PubMed] [Google Scholar]; e) Yu KL, Zhang Y, Civiello RL, Kadow KF, Cianci C, Krystal M, Meanwell NA. Bioorg Med Chem Lett. 2003;13:2141–2144. doi: 10.1016/s0960-894x(03)00383-4. [DOI] [PubMed] [Google Scholar]; f) Borowski P, Deinert J, Schalinski S, Bretner M, Ginalski K, Kulikowski T, Shugar D. Eur J Biochem. 2003;270:1645–1653. doi: 10.1046/j.1432-1033.2003.03540.x. [DOI] [PubMed] [Google Scholar]; g) Caliendo G, Greco G, Grieco P, Novellino E, Perissutti E, Santagada V, Barbarulo D, Esposito E, De Blasi A. Eur J Med Chem. 1996;31:207–213. [Google Scholar]; h) Caliendo G, Di Carlo R, Greco G, Meli R, Novellino E, Perissutti E, Santagada V. Eur J Med Chem. 1995;30:77–84. [Google Scholar]
- 4.a) Thomas WD, Powers J, Sullivan EJ, Punna S, Novack A, Hu C, Pennell AMK, Zhang P, Melikian A, Charvat TT, Ungashe S. AU 2008302672 A1 Aust Pat Appl. 2009; b) Mo D, Shi W, Ma X, Bi H, Su G, Chen C, Zou N. CN 105820132 A Faming Zhuanlo Shenqing. 2016
- 5.Ohsawa F, Yamada S, Yakushiji N, Shinozaki R, Nakayama M, Kawata K, Hagaya M, Kobayashi T, Kohara K, Furusawa Y, Fujiwara C, Ohta Y, Makishima M, Naitou H, Tai A, Yoshikawa Y, Yasui H, Kakuta H. J Med Chem. 2013;56:1865–1877. doi: 10.1021/jm400033f. [DOI] [PubMed] [Google Scholar]
- 6.Palmer WS, Alam M, Arzeno HB, Chang KC, Dunn JP, Goldstein DM, Gong L, Goyal B, Hermann JC, Hogg JH, Hseih G, Jahangir A, Janson C, Jin S, Kammlott RU, Kuglstatter A, Lukas C, Michoud C, Niu L, Reuter DC, Shao A, Silva T, Trejo-Martin TA, Stein K, Tan YC, Tivitmahaisoon P, Tran P, Wagner P, Weller P, Wu SY. Bioorg Med Chem Lett. 2013;23:1486–1492. doi: 10.1016/j.bmcl.2012.12.047. [DOI] [PubMed] [Google Scholar]
- 7.Narinder PS, Rajesh K, Deo NP, Sarita S, Om S. Int J Biol Chem. 2011;5:193–199. [Google Scholar]
- 8.Awasthi SK, Mishra N, Dixit SK, Singh A, Yadav M, Yadav SS, Rathaur S. Am J Trop Med Hyg. 2009;80:764–768. [PubMed] [Google Scholar]
- 9.Mishra N, Arora P, Kumar B, Mishra LC, Bhattacharya A, Awasthi SK, Bhasin VK. Eur J Med Chem. 2008;43:1530–1535. doi: 10.1016/j.ejmech.2007.09.014. [DOI] [PubMed] [Google Scholar]
- 10.a) Finšgar M, Milošev I. Corros Sci. 2010;52:2737–2749. [Google Scholar]; b) Allam NK, Nazeer AA. J Appl Electrochem. 2009;39:961–969. [Google Scholar]; c) Antonijevic MM, Petrovic MB. Int J Electrochem Sci. 2008;3:1–28. [Google Scholar]
- 11.Weiss S, Jakobs J, Reemtsma T. Environ Sci Technol. 2006;40:7193–7199. doi: 10.1021/es061434i. [DOI] [PubMed] [Google Scholar]
- 12.Theys RD, Sosnovsky G. Chem Rev. 1997;97:83–132. doi: 10.1021/cr941191p. [DOI] [PubMed] [Google Scholar]
- 13.a) Kale RR, Prasad V, Mohapatra PP, Tiwari VK. Monatsh Chem. 2010;141:1159–1182. [Google Scholar]; b) Katritzky AR, Suzuki K, Wang Z. Synlett. 2005:1656–1665. [Google Scholar]; c) Katritzky AR, Rogovoy BV. Chem Eur J. 2003;9:4586–4593. doi: 10.1002/chem.200304990. [DOI] [PubMed] [Google Scholar]; d) Paio A, Zaramella A, Ferritto R, Conti N, Marchioro C, Seneci P. J Comb Chem. 1999;1:317–325. [Google Scholar]; e) Katritzky AR, Rachwal S, Hitchings GJ. Tetrahedron. 1991;47:2683–2732. [Google Scholar]
- 14.See for examples:; a) Kallitsakis M, Loukopoulos E, Abdul-Sada A, Tizzard GJ, Coles SJ, Kostakis GE, Lykakis IN. Adv Synth Catal. 2016;359:138–145. [Google Scholar]; b) Go MJ, Lee JM, Lee KM, Oh CH, Chang H, Park KH, Kim SH, Kim M, Park HR, Park MH, Kim Y, Lee J. Polyhedron. 2014;67:286–294. [Google Scholar]; c) Du W, Wu P, Wang Q, Yu Z. Organometallics. 2013;32:3083–3090. [Google Scholar]; d) Verma AK, Jha RR, Chaudhary R, Tiwari RK, Danodia AK. Adv Synth Catal. 2013;355:421–438. [Google Scholar]; e) Yan W, Ye X, Akhmedov NG, Peterson JL, Shi X. Org Lett. 2012;14:2358–2361. doi: 10.1021/ol300778e. [DOI] [PubMed] [Google Scholar]
- 15.For some recent examples, see:; a) Okolotowicz KJ, Bushway P, Lanier M, Gilley C, Mercola M, Cashman JR. Bioorg Med Chem. 2015;23:5282–5292. doi: 10.1016/j.bmc.2015.07.073. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Kakuta H, Yakushiji N, Shinozaki R, Ohsawa F, Yamada S, Ohta Y, Kawata K, Nakayama M, Hagaya M, Oohashi T, Yasui H, Yoshikawa Y. ACS Med Chem Lett. 2012;3:427–432. doi: 10.1021/ml300055n. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Chen M, Buchwald SL. Angew Chem Int Ed. 2013;52:4247–4250. doi: 10.1002/anie.201300615. [DOI] [PubMed] [Google Scholar]; d) Nolan KA, Humphries MP, Barnes J, Doncaster JR, Caraher MC, Tirelli N, Bryce RA, Whitehead RC, Stratford IJ. Bioorg Med Chem. 2010;15:696–706. doi: 10.1016/j.bmc.2009.11.059. [DOI] [PubMed] [Google Scholar]
- 16.Łukasik E, Wróbel Z. Synlett. 2014;25:1987–1990. [Google Scholar]
- 17.a) Campbell-Verduyn L, Elsinga PH, Mirfeizi L, Dierckx RA, Feringa BL. Org Biomol Chem. 2008;6:3461–3463. doi: 10.1039/b812403e. [DOI] [PubMed] [Google Scholar]; b) Shi F, Waldo JP, Chen Y, Larock RC. Org Lett. 2008;10:2409–2412. doi: 10.1021/ol800675u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kumar RK, Ali MA, Punniyamurthy T. Org Lett. 2012;13:2102–2105. doi: 10.1021/ol200523a. [DOI] [PubMed] [Google Scholar]
- 19.Zhou J, He J, Wang B, Yang W, Ren H. J Am Chem Soc. 2011;133:6868–6870. doi: 10.1021/ja2007438. [DOI] [PubMed] [Google Scholar]
- 20.López-Alvarado P, Avendaño C, Menéndez JC. J Org Chem. 1995;60:5678–5682. [Google Scholar]
- 21.Antilla JC, Baskin JM, Barder TE, Buchwald SL. J Org Chem. 2004;69:5578–5587. doi: 10.1021/jo049658b. [DOI] [PubMed] [Google Scholar]
- 22.Lee HG, Won JE, Kim MJ, Park SE, Jung KJ, Kim BR, Lee SG, Yoon YJ. J Org Chem. 2009;74:5675–5678. doi: 10.1021/jo900752z. [DOI] [PubMed] [Google Scholar]
- 23.Mukhopadhyay C, Tapaswi PK, Butcher RJ. Org Biomol Chem. 2010;8:4720–4729. doi: 10.1039/c0ob00177e. [DOI] [PubMed] [Google Scholar]
- 24.Liu QL, Wen DD, Huang CC, Li QL, Zhu YM. Helv Chim Acta. 2010;93:1350–1354. [Google Scholar]
- 25.Kale RR, Prasad V, Hussain HA, Tiwari VK. Tetrahedron Lett. 2010;51:5740–5743. doi: 10.1016/j.tetlet.2010.08.083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sun K, Zhu Z, Sun J, Liu L, Wang X. J Org Chem. 2016;81:1476–1483. doi: 10.1021/acs.joc.5b02593. [DOI] [PubMed] [Google Scholar]
- 27.Wang ZX, Shi WM, Bi HY, Li XH, Su GF, Mo DL. J Org Chem. 2016;81:8014–8021. doi: 10.1021/acs.joc.6b01390. [DOI] [PubMed] [Google Scholar]
- 28.Gurram V, Akula HK, Garlapati R, Pottabathini N, Lakshman MK. Adv Synth Catal. 2015;357:451–462. doi: 10.1002/adsc.201400889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kokatla HP, Thomson PF, Bae S, Doddi VR, Lakshman MK. J Org Chem. 2011;76:7842–7848. doi: 10.1021/jo201192c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Basava V, Yang L, Pradhan P, Lakshman MK. Org Biomol Chem. 2016;14:7069–7083. doi: 10.1039/c6ob01170e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Londregan AT, Piotrowski DW, Xiao J. Synlett. 2013;24:2695–2700. [Google Scholar]
- 32.Bosch R, Jung G, Winter W. Acta Cryst. 1983;C39:1089–1092. [Google Scholar]
- 33.Horiki K. Tetrahedron Lett. 1977;18:1897–1900. [Google Scholar]
- 34.Katritzky AR, Malhotra N, Fan WQ, Anders E. J Chem Soc Perkin Trans. 1991;2:1545–1547. [Google Scholar]
- 35.Brink BD, DeFrancisco JR, Hillner JA, Linton BR. J Org Chem. 2011;76:5258–5263. doi: 10.1021/jo200346r. [DOI] [PubMed] [Google Scholar]
- 36.Chan DMT, Monaco KL, Wang RP, Winters MP. Tetrahedron Lett. 1998;39:2933–2936. [Google Scholar]
- 37.Evans DA, Katz JL, West TR. Tetrahedron Lett. 1998;39:2937–2940. [Google Scholar]
- 38.Lam PYS, Clark CG, Saubern S, Adams J, Winters MP, Chan DMT, Combs A. Tetrahedron Lett. 1998;39:2941–2944. [Google Scholar]
- 39.Lam PYS, Clark CG, Saubern S, Adams J, Averill KM, Chan DMT, Combs A. Synlett. 2000:674–676. [Google Scholar]
- 40.Shi WM, Liu FP, Wang ZX, Bi HY, Liang C, Xu LP, Su GF, Mo DL. Adv Synth Catal. 2017;359:2741–2746. [Google Scholar]
- 41.CCDC 1812840 (compound 1) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/cif.
- 42.See for examples:; a) Leonard NJ, Golankiewicz K. J Org Chem. 1969;34:359–365. [Google Scholar]; b) Fu J, Yang Y, Zhang XW, Mao WJ, Zhang XM, Zhu HL. Bioorg Med Chem. 2010;18:8457–8462. doi: 10.1016/j.bmc.2010.10.049. [DOI] [PubMed] [Google Scholar]
- 43.500 MHz 1H NMR data for 5-chloro-1-(p-tolyl)-1H-benzotriazole (44) in CDCl3: 8.12 (s, 1H, ArH), 7.66–7.62 (m, 3H, ArH), 7.50 (d, J = 8.8 Hz, 1H, ArH), 7.42 (d, J = 7.2 Hz, 2H, ArH), 2.48 (s, 3H, Me). 300 1H NMR data for 6-chloro-1-(p-tolyl)-1H-benzotriazole in CDCl3:[23] 8.05 (d, J = 8.6 Hz, 1H, ArH), 7.71 (d, J = 1.5 Hz, 1H, ArH), 7.61 (d, J = 8.3 Hz, 2H, ArH), 7.40 (2 d merged as a t, J = 8.3 and 8.6 Hz, 3H, ArH), 2.48 (s, 3H, Me).
- 44.CCDC 1812841 (compound 44) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/cif.
- 45.Boyle FT, Jones RAY. J Chem Soc Perkin Trans. 1973;2:160–164. [Google Scholar]
- 46.King AE, Brunold TC, Stahl SS. J Am Chem Soc. 2009;131:5044–5045. doi: 10.1021/ja9006657. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
